COGT logo

Cogent Biosciences, Inc. (COGT) EBITDA

Annual EBITDA:

-$271.59M-$67.05M(-32.78%)
December 31, 2024

Summary

  • As of today, COGT annual EBITDA is -$271.59 million, with the most recent change of -$67.05 million (-32.78%) on December 31, 2024.
  • During the last 3 years, COGT annual EBITDA has fallen by -$198.03 million (-269.21%).
  • COGT annual EBITDA is now -4134.96% below its all-time high of -$6.41 million, reached on December 31, 2015.

Performance

COGT EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTincome statement metrics

Quarterly EBITDA:

-$82.21M-$7.78M(-10.46%)
September 30, 2025

Summary

  • As of today, COGT quarterly EBITDA is -$82.21 million, with the most recent change of -$7.78 million (-10.46%) on September 30, 2025.
  • Over the past year, COGT quarterly EBITDA has dropped by -$7.89 million (-10.62%).
  • COGT quarterly EBITDA is now -3318.79% below its all-time high of $2.55 million, reached on December 31, 2019.

Performance

COGT Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTincome statement metrics

TTM EBITDA:

-$303.00M-$7.89M(-2.67%)
September 30, 2025

Summary

  • As of today, COGT TTM EBITDA is -$303.00 million, with the most recent change of -$7.89 million (-2.67%) on September 30, 2025.
  • Over the past year, COGT TTM EBITDA has dropped by -$46.61 million (-18.18%).
  • COGT TTM EBITDA is now -5132.33% below its all-time high of -$5.79 million, reached on March 31, 2017.

Performance

COGT TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

COGT EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-32.8%-10.6%-18.2%
3Y3 Years-269.2%-148.3%-140.9%
5Y5 Years-779.4%-787.1%-1447.8%

COGT EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-269.2%at low-148.3%at low-140.9%at low
5Y5-Year-779.4%at low-787.1%at low-1447.8%at low
All-TimeAll-Time-4135.0%at low-3318.8%at low-5132.3%at low

COGT EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
-$82.21M(-10.5%)
-$303.00M(-2.7%)
Jun 2025
-
-$74.42M(-0.9%)
-$295.11M(-3.9%)
Mar 2025
-
-$73.80M(-1.7%)
-$284.00M(-4.6%)
Dec 2024
-$271.59M(-32.8%)
-$72.58M(+2.3%)
-$271.54M(-5.9%)
Sep 2024
-
-$74.32M(-17.4%)
-$256.40M(-6.5%)
Jun 2024
-
-$63.31M(-3.2%)
-$240.80M(-7.8%)
Mar 2024
-
-$61.34M(-6.8%)
-$223.37M(-9.2%)
Dec 2023
-$204.54M(-44.1%)
-$57.43M(+2.2%)
-$204.54M(-7.7%)
Sep 2023
-
-$58.73M(-28.0%)
-$189.92M(-15.6%)
Jun 2023
-
-$45.87M(-7.9%)
-$164.30M(-6.6%)
Mar 2023
-
-$42.51M(+0.7%)
-$154.19M(-7.8%)
Dec 2022
-$141.96M(-93.0%)
-$42.81M(-29.3%)
-$143.03M(-13.7%)
Sep 2022
-
-$33.11M(+7.4%)
-$125.79M(-11.9%)
Jun 2022
-
-$35.76M(-14.1%)
-$112.45M(-19.7%)
Mar 2022
-
-$31.35M(-22.6%)
-$93.97M(-24.6%)
Dec 2021
-$73.56M
-$25.57M(-29.3%)
-$75.40M(-26.1%)
Sep 2021
-
-$19.77M(-14.4%)
-$59.78M(-21.3%)
Jun 2021
-
-$17.28M(-35.2%)
-$49.28M(-26.3%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$12.78M(-28.5%)
-$39.02M(-21.6%)
Dec 2020
-$34.57M(-11.9%)
-$9.95M(-7.4%)
-$32.08M(-63.9%)
Sep 2020
-
-$9.27M(-32.1%)
-$19.58M(+11.1%)
Jun 2020
-
-$7.02M(-20.0%)
-$22.03M(+22.1%)
Mar 2020
-
-$5.85M(-328.9%)
-$28.28M(+16.7%)
Dec 2019
-$30.89M(+11.0%)
$2.55M(+121.8%)
-$33.95M(+24.8%)
Sep 2019
-
-$11.72M(+11.7%)
-$45.15M(-3.4%)
Jun 2019
-
-$13.27M(-15.3%)
-$43.68M(-10.5%)
Mar 2019
-
-$11.51M(-33.0%)
-$39.52M(-14.0%)
Dec 2018
-$34.68M(-38.8%)
-$8.65M(+15.6%)
-$34.68M(-6.4%)
Sep 2018
-
-$10.25M(-12.4%)
-$32.60M(-11.6%)
Jun 2018
-
-$9.11M(-36.6%)
-$29.23M(-13.0%)
Mar 2018
-
-$6.67M(-1.5%)
-$25.86M(-3.5%)
Dec 2017
-$24.98M(-37.0%)
-$6.57M(+4.3%)
-$24.98M(-35.7%)
Sep 2017
-
-$6.87M(-19.5%)
-$18.41M(-59.5%)
Jun 2017
-
-$5.75M(+0.8%)
-$11.54M(-99.2%)
Mar 2017
-
-$5.79M
-$5.79M
Dec 2016
-$18.24M(-184.4%)
-
-
Dec 2015
-$6.41M
-
-

FAQ

  • What is Cogent Biosciences, Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. annual EBITDA year-on-year change?
  • What is Cogent Biosciences, Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. quarterly EBITDA year-on-year change?
  • What is Cogent Biosciences, Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. TTM EBITDA year-on-year change?

What is Cogent Biosciences, Inc. annual EBITDA?

The current annual EBITDA of COGT is -$271.59M

What is the all-time high annual EBITDA for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high annual EBITDA is -$6.41M

What is Cogent Biosciences, Inc. annual EBITDA year-on-year change?

Over the past year, COGT annual EBITDA has changed by -$67.05M (-32.78%)

What is Cogent Biosciences, Inc. quarterly EBITDA?

The current quarterly EBITDA of COGT is -$82.21M

What is the all-time high quarterly EBITDA for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high quarterly EBITDA is $2.55M

What is Cogent Biosciences, Inc. quarterly EBITDA year-on-year change?

Over the past year, COGT quarterly EBITDA has changed by -$7.89M (-10.62%)

What is Cogent Biosciences, Inc. TTM EBITDA?

The current TTM EBITDA of COGT is -$303.00M

What is the all-time high TTM EBITDA for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high TTM EBITDA is -$5.79M

What is Cogent Biosciences, Inc. TTM EBITDA year-on-year change?

Over the past year, COGT TTM EBITDA has changed by -$46.61M (-18.18%)
On this page